Form S-8 NEUROCRINE BIOSCIENCES
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/17/2026
- Wall Street indexes slip as oil prices rise, retail results awaited
- Trump threatens to bomb Oman over Iran stance
- Why this Wall Street strategist says the "trade is long gold"
- U.S. EV market shows signs of bottoming out: Bernstein
- Micron rises as White House presses Apple to avoid Chinese memory chips
- Wall Street indexes slip as oil prices rise, retail results awaited
- Trump threatens to bomb Oman over Iran stance
- L3Harris CEO steps down amid conduct review, shares drop
- Reddit leads social media platforms in revenue growth per user
- BofA sees Micron EPS topping $230 by FY30, calls peak fears overblown
Neurocrine Bio. (NBIX) PT Raised to $158 at Citi
August 1, 2024 3:55 PM EDTCiti analyst David Hoang raised the price target on Neurocrine Bio. (NASDAQ: NBIX) to $158.00 (from $150.00) while maintaining a Neutral rating.
The analyst comments "NBIX reported 2Q24 results and corporate updates. Ingrezza surprised with a healthy beat ~$40M above consensus and ~$50M above our... More
